SCTX · Scribe Therapeutics, Inc. · Held by Funds
$17.05
+0.85 (+5.25%)
At close · Nov 4
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 2, 2026
The latest filing states the doubt was alleviated.
“Substantial doubt about our ability to continue as a going concern existed as of June 30, 2026 and was alleviated as a result of the completion of our initial public offering and concurrent private placement, which resulted in aggregate net proceeds of approximately $140.7 million.”View the 10-Q filed Sep 2, 2026
Market Cap
$320.27M
Shares
18.93M
Volume · Nov 4
204.03K
Avg daily vol (3M)
375.75K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding SCTX
7 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| ARK Genomic Revolution ETF | ARKG | 352,097 | $6,858,850 | 0.44% | Long | 2026-07-31 | |
| Franklin Biotechnology Discovery Fund | — | 135,567 | $2,640,845 | 0.23% | Long | 2026-07-31 | |
| Fidelity Nasdaq Composite Index Fund | FNCMX | 19,247 | $587,803 | 0.00% | Long | 2026-08-31 | |
| Tema Healthcare AI ETF | HLTH | 1,836 | $56,071 | 0.73% | Long | 2026-08-31 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 500 | $15,270 | 0.00% | Long | 2026-08-31 | |
| BlackRock Advantage Small Cap Core Fund | — | 487 | $14,873 | 0.00% | Long | 2026-08-31 | |
| Strategic Advisers U.S. Total Stock Fund | FSAKX | 138 | $4,215 | 0.00% | Long | 2026-08-31 |
Showing 1–7 of 7 positions